Literature DB >> 9449592

Sling incision with associated vaginal wall interposition for obstructed voiding secondary to suburethral sling procedure.

M T McLennan1, A E Bent.   

Abstract

Obstructed voiding is a well recognized complication following a suburethral sling procedure. Current methods of transvaginal and transabdominal urethrolysis have had variable success rates in relieving the obstruction, and do not restabilize the urethra to prevent potential postoperative stress incontinence. We report on a procedure used in 4 cases which addresses both of these issues. All patients had persistent urinary retention beyond 8 weeks after a suburethral sling procedure. An oupatient procedure consisting of sling incision and associated tissue interposition (vaginal wall in three cases and fascia lata in one) was successful in relieving the obstruction. Continence status was maintained in 3 of the 4 patients. There were no major complications of this outpatient procedure.

Entities:  

Mesh:

Year:  1997        PMID: 9449592     DOI: 10.1007/bf02764852

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  14 in total

1.  Pubovaginal fascial sling for the treatment of complicated stress urinary incontinence.

Authors:  J G Blaivas; B Z Jacobs
Journal:  J Urol       Date:  1991-06       Impact factor: 7.450

2.  Simplified surgical approach to bladder outlet obstruction following pubovaginal sling.

Authors:  G M Ghoniem; A N Elgamasy
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

3.  Impaired voiding efficiency and retention.

Authors:  R Turner-Warwick
Journal:  Clin Obstet Gynaecol       Date:  1978-04

4.  A suburethral sling procedure with polytetrafluoroethylene for the treatment of genuine stress incontinence in patients with low urethral closure pressure.

Authors:  N S Horbach; J S Blanco; D R Ostergard; A E Bent; J L Cornella
Journal:  Obstet Gynecol       Date:  1988-04       Impact factor: 7.661

5.  Voiding dysfunction following cystourethropexy: its evaluation and management.

Authors:  G D Webster; K J Kreder
Journal:  J Urol       Date:  1990-09       Impact factor: 7.450

6.  Experience with pubovaginal slings for urinary incontinence at the University of Michigan.

Authors:  E J McGuire; C J Bennett; J A Konnak; L P Sonda; J A Savastano
Journal:  J Urol       Date:  1987-09       Impact factor: 7.450

7.  Voiding after Burch colposuspension and effects of concomitant pelvic surgery: correlation with preoperative voiding mechanism.

Authors:  E H Sze; J R Miklos; M M Karram
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

8.  Management of urethral obstruction with transvaginal urethrolysis.

Authors:  H E Foster; E J McGuire
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

9.  The Marlex sling operation for the treatment of recurrent stress urinary incontinence: a 16-year review.

Authors:  J E Morgan; G A Farrow; F E Stewart
Journal:  Am J Obstet Gynecol       Date:  1985-01-15       Impact factor: 8.661

10.  Transvaginal urethrolysis after obstructive urethral suspension procedures.

Authors:  E J McGuire; W Letson; S Wang
Journal:  J Urol       Date:  1989-10       Impact factor: 7.450

View more
  4 in total

Review 1.  Voiding dysfunction after surgery for stress incontinence: literature review and survey results.

Authors:  James S Dunn; Alfred E Bent; R Mark Ellerkman; Mikio A Nihira; Clifford F Melick
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-12-19

Review 2.  Evaluation and management of urinary retention after a suburethral sling procedure in women.

Authors:  Lysanne Campeau; Tala Al-Afraa; Jacques Corcos
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

3.  Predicting for postoperative incontinence following sling incision.

Authors:  Timothy Yoost; Ross Rames; Brett Lebed; Robin Bhavsar; Eric Rovner
Journal:  Int Urogynecol J       Date:  2010-12-03       Impact factor: 2.894

Review 4.  Methods and results of urethrolysis.

Authors:  Jonathan S Starkman; Harriette Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.